Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

NCR lowers guidance after disappointing ATM orders in the third quarter

Also featured: CAI International, Daqo New Energy, NCR Corporation, Supervalu, Skechers USA Inc, Celgene Corporation and Atlassian Corporation

A look at the day's big movers

RISERS

CAI International Inc (NYSE:CAI), up 17% at US$36.68

Transportation and logistics company CAI was going places in early trades, after it reported net income for the third quarter of US$69.1mln, versus a loss of US$5.5mln the year before.

Daqo New Energy Corp (NYSE:DQ), up 10% at US$36.04

The manufacturer of high-purity poly-silicon for the global solar photo-voltaic industry said its board has officially approved the company's Phase 3B expansion plan for its poly-silicon facilities in Xinjiang.

FALLERS

NCR Corporation (NYSE:NCR), down 11% at US$33.04

The cash dispensing machine maker said orders for automatic telling machines (ATMs) in the third quarter were disappointing, resulting in the company reducing full-year guidance.

Supervalu Inc (NYSE:SVU), down 7% at US$14.60

The wholesale distributor made a net loss of US$25mln in the 12 weeks to 9 September, versus a profit of US$31mln in the corresponding period of last year. It also announced it was buying Associated Grocers of Florida for US$180mln.

Pre-market movers

Online payments specialist Paypal Holdings Inc (NASDAQ:PYPL) was wanted in after-hours trading after topping expectations with its earnings.

The firm also raised its outlook for the full year, now expecting revenues in the range of between US$12.92bn and US$12.98bn.

READ Paypal Holdings boosted by growth in mobile as it raises full year outlook

The shares were up almost 4% at US$69.84 in screen-based trading.

That rise was put in the shade by the 27% surge to US$30.45 by Skechers USA Inc (NYSE:SKX), the footwear company.

Third quarter earnings per share of 59 cents were 16 cents higher than the market had been expecting.

“Third quarter net sales of US$1.095 billion set a new quarterly record for the Company, surpassing our previous record in the first quarter earlier this year by $22 million, and resulted in a new nine month record with sales exceeding $3 billion,” said David Weinberg, chief operating officer and chief financial officer of Skechers.

Fiscal first quarter results from collaboration software outfit Atlassian Corporation PLC (NASDAQ:TEAM) sparked a surge in demand for the shares, which rose 12% to US$45.10 in after-hours trading.

Total revenue in the three months to the end of September was US$193.8, up 42% from US$136.8 million for the first quarter of fiscal 2017.

Adjusted net income was US$29.9mln, versus US$22.7mln the year before.

Going the other way was Celgene Corporation (NASDAQ:CELG), the cancer and inflammatory diseases drugs developer.

The shares retreated 5.5% to US$128.50 after the company announced it would not take a possible Crohn’s disease treatment to Phase 3 trial.

READ Celgene stock drops on drug development disappointment

Medtech firm Intuitive Surgical Inc (NASDAQ:ISRG) found the market hard to please.

The shares dipped 3.2% to US$345.90, despite reporting third quarter revenues and profits that beat Wall Street's consensus forecasts.

Net income weighed in at US$323.8mln, equivalent to US$2.77 a share; that was up from US$245.7mln (US$2.06 a share) the year before ans better than the US$1.99 a share analysts had been expecting.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK